{{Rsnum
|rsid=1962142
|Gene=NFE2L2
|Chromosome=2
|position=177248756
|Orientation=minus
|GMAF=0.1267
|Gene_s=NFE2L2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 83.2 | 16.8 | 0.0
| HCB | 60.6 | 34.3 | 5.1
| JPT | 68.1 | 28.3 | 3.5
| YRI | 93.2 | 6.1 | 0.7
| ASW | 89.5 | 10.5 | 0.0
| CHB | 60.6 | 34.3 | 5.1
| CHD | 63.9 | 33.3 | 2.8
| GIH | 87.1 | 12.9 | 0.0
| LWK | 86.4 | 13.6 | 0.0
| MEX | 65.5 | 27.6 | 6.9
| MKK | 75.6 | 23.1 | 1.3
| TSI | 80.4 | 18.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21774808
|Title=An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV1: a longitudinal retrospective cohort study
|OA=1
}}

{{PMID Auto
|PMID=22964583
|Title=Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}